Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Syner-Medica is a UK-based healthcare company operating within the broader Syner-Med Group, focused on licensing, development, and commercialisation of specialty medicines and medical devices for unmet clinical needs. Its marketed portfolio includes urokinase thrombolytic products sold under the Syner-KINASE and Urokinase Syner-Medica brands, as well as urology and vascular-access devices such as Hyacyst and C-Lock through partner networks. The company appears to function primarily as a specialty pharma commercialisation and distribution platform rather than a research-stage biotech developer. Therapeutic focus areas highlighted by the group include vascular access, urology, and urogynaecology, with commercial reach extending across the UK and multiple European markets. Corporate records show active UK and Netherlands entities used to market and hold pharmaceutical licenses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Syner-Medica.